Merck’s success stems from translating research into life-saving medical breakthroughs. From Merck’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we’ve become an industry leader in bringing innovative new medicines to patients. Approximately half of our pipeline is attributable to acquisitions, alliance partnerships and patents with our team executing 76 significant business development transactions in 2023. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life. Learn more at www.merck.com/licensing.